Drug Shortage Report for KETOROLAC TROMETHAMINE INJECTION, USP
Report ID | 71575 |
Drug Identification Number | 02244947 |
Brand name | KETOROLAC TROMETHAMINE INJECTION, USP |
Common or Proper name | Ketorolac Injection |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | KETOROLAC TROMETHAMINE |
Strength(s) | 30MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAMUSCULAR |
Packaging size | 1mL |
ATC code | M01AB |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2019-01-09 |
Actual start date | |
Estimated end date | |
Actual end date | 2019-01-18 |
Shortage status | Resolved |
Updated date | 2019-01-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2019-01-19 | English | Compare |
v5 | 2019-01-18 | French | Compare |
v4 | 2019-01-18 | English | Compare |
v3 | 2019-01-10 | English | Compare |
v2 | 2019-01-08 | French | Compare |
v1 | 2019-01-08 | English | Compare |
Showing 1 to 6 of 6